CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$54.78 -0.65 (-1.18%)
As of: Oct 2, 2026 · 2:06 PM EDT

CRISPR Therapeutics AG (CRSP) Net Equity Issued and Repurchased (2016 - 2026)

Updated

CRISPR Therapeutics AG's Net Equity Issued and Repurchased came in at $8.3 million for Q2 2026, compared with -$22,000 a year earlier and up 34.8% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, CRISPR Therapeutics AG reported Net Equity Issued and Repurchased of $404.06 million; for FY2025, it came in at $398.09 million, up 32.4% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -16.5% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $300.7 million in FY2024 (+819.0%), $32.72 million in FY2023 (-13.0%), $37.62 million in FY2022 (-82.4%) and $213.27 million in FY2021 (-78.3%).
  • The five-year range for quarterly Net Equity Issued and Repurchased is -$1.01 million (Q2 2024) to $280.75 million (Q1 2024).
  • Year-over-year, Net Equity Issued and Repurchased increased in three of the last five quarters, with growth averaging 174.5%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q4 2025 (growth of 645.3%), and the weakest in Q1 2025 (a decline of 97.0%).
  • Business Quant data shows CRSP's Net Equity Issued and Repurchased at $6.16 million (Q1 2026), $111.49 million (Q4 2025) and $278.11 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 CRISPR Therapeutics AG 5.35 Bn 5.35 Bn - 8.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.30 Mn
Mar 31, 2026 6.16 Mn
Dec 31, 2025 111.49 Mn
Sep 30, 2025 278.11 Mn
Jun 30, 2025 -22,000.00
Mar 31, 2025 8.52 Mn
Dec 31, 2024 14.96 Mn
Sep 30, 2024 6.00 Mn
Jun 30, 2024 -1.01 Mn
Mar 31, 2024 280.75 Mn
Dec 31, 2023 9.00 Mn
Sep 30, 2023 1.56 Mn
Jun 30, 2023 16.77 Mn
Mar 31, 2023 5.40 Mn
Dec 31, 2022 2.48 Mn
Sep 30, 2022 14.14 Mn
Jun 30, 2022 10.35 Mn
Mar 31, 2022 10.65 Mn
Jun 30, 2021 -1.33 Mn
Mar 31, 2021 214.59 Mn
API Access

CRISPR Therapeutics AG Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CRSP&period=max&api_key=YOUR_API_KEY